Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | Krystal Biotech, Inc. | 2,565,555 | 9.1% | EDGAR |
SC 13G/A | 2024-02-14 | Redmile Group, LLC | Krystal Biotech, Inc. | 1,733,189 | 6.1% | EDGAR |
SC 13G | 2024-02-13 | VANGUARD GROUP INC | Krystal Biotech, Inc. | 2,435,774 | 8.6% | EDGAR |
SC 13G/A | 2024-02-12 | FMR LLC | Krystal Biotech, Inc. | 3,349,474 | 11.9% | EDGAR |
SC 13G/A | 2024-02-09 | FMR LLC | Krystal Biotech, Inc. | 2,385,898 | 8.5% | EDGAR |
SC 13G/A | 2024-01-29 | BlackRock Inc. | Krystal Biotech, Inc. | 1,809,377 | 6.4% | EDGAR |
SC 13G/A | 2023-05-10 | FMR LLC | Krystal Biotech, Inc. | 2,613,272 | 10.1% | EDGAR |
SC 13G/A | 2023-02-14 | Point72 Asset Management, L.P. | Krystal Biotech, Inc. | 556,252 | 2.2% | EDGAR |
SC 13G/A | 2023-02-14 | Redmile Group, LLC | Krystal Biotech, Inc. | 1,896,645 | 7.4% | EDGAR |
SC 13G | 2023-02-14 | Avoro Capital Advisors LLC | Krystal Biotech, Inc. | 1,410,000 | 5.5% | EDGAR |
SC 13G/A | 2023-02-09 | FMR LLC | Krystal Biotech, Inc. | 2,108,853 | 8.2% | EDGAR |
SC 13G/A | 2023-02-01 | BlackRock Inc. | Krystal Biotech, Inc. | 1,698,425 | 6.6% | EDGAR |
SC 13G/A | 2022-02-14 | Point72 Asset Management, L.P. | Krystal Biotech, Inc. | 1,856,156 | 7.5% | EDGAR |
SC 13G/A | 2022-02-14 | Redmile Group, LLC | Krystal Biotech, Inc. | 1,820,898 | 7.3% | EDGAR |
SC 13G/A | 2022-02-09 | FMR LLC | Krystal Biotech, Inc. | 1,978,289 | 7.9% | EDGAR |
SC 13G/A | 2022-02-03 | BlackRock Inc. | Krystal Biotech, Inc. | 1,605,496 | 6.4% | EDGAR |
SC 13G | 2021-12-06 | Point72 Asset Management, L.P. | Krystal Biotech, Inc. | 1,342,200 | 5.4% | EDGAR |
SC 13G/A | 2021-03-09 | Sun Pharma (Netherlands) B.V. | Krystal Biotech, Inc. | 914,107 | 4.1% | EDGAR |
SC 13G/A | 2021-02-16 | PRICE T ROWE ASSOCIATES INC /MD/ | Krystal Biotech, Inc. | 912 | 0.0% | EDGAR |
SC 13G/A | 2021-02-16 | Redmile Group, LLC | Krystal Biotech, Inc. | 1,675,036 | 8.5% | EDGAR |